Sex-specific signaling through Toll-Like Receptors 2 and 4 contributes to survival outcome of Coxsackievirus B3 infection in C57Bl/6 mice by Brian J Roberts et al.
Roberts et al. Biology of Sex Differences 2012, 3:25
http://www.bsd-journal.com/content/3/1/25RESEARCH Open AccessSex-specific signaling through Toll-Like Receptors
2 and 4 contributes to survival outcome of
Coxsackievirus B3 infection in C57Bl/6 mice
Brian J Roberts1, Julie A Dragon2, Mohamad Moussawi1 and Sally A Huber1*Abstract
Background: Coxsackievirus B3 (CVB3) induces myocarditis, an inflammatory heart disease, which affects men more
than women. Toll-like receptor (TLR) signaling has been shown to determine the severity of CVB3-induced
myocarditis. No direct role for signaling through TLR2 had been shown in myocarditis although published studies
show that cardiac myosin is an endogenous TLR2 ligand and stimulates pro-inflammatory cytokine expression by
dendritic cells in vitro. The goal of this study is to determine which TLRs show differential expression in CVB3
infected mice corresponding to male susceptibility and female resistance in this disease.
Methods: Male and female C57Bl/6 mice were infected with 102 PFU CVB3 and killed on day 3 or 6 post infection.
Hearts were evaluated for virus titer, myocardial inflammation, and TLR mRNA expression by PCR array and
microarray analysis. Splenic lymphocytes only were evaluated by flow cytometry for the number of TLR+/CD3+,
TLR+/CD4+, TLR+F4/80+ and TLR+/CD11c+ subpopulations and the mean fluorescence intensity to assess
upregulation of TLR expression on these cells. Mice were additionally treated with PAM3CSK4 (TLR2 agonist) or
ultrapure LPS (TLR4 agonist) on the same day as CVB3 infection or 3 days post infection to confirm their role in
myocarditis susceptibility.
Results: Despite equivalent viral titers, male C57Bl/6 mice develop more severe myocarditis than females by day 6
after infection. Microarray analysis shows a differential expression of TLR2 at day 3 with female mice having higher
levels of TLR2 gene expression compared to males. Disease severity correlates to greater TLR4 protein expression
on splenic lymphocytes in male mice 3 days after infection while resistance in females correlates to preferential
TLR2 expression, especially in spleen lymphocytes. Treating male mice with PAM reduced mortality from 55% in
control CVB3 infected animals to 10%. Treating female mice with LPS increased mortality from 0% in control
infected animals to 60%.
Conclusion: CVB3 infection causes an up-regulation of TLR2 in female and of TLR4 in male mice and this
differential expression between the sexes contributes to disease resistance of females and susceptibility
of males. While previous reports demonstrated a pathogenic role for TLR4 this is the first report that TLR2 is
preferentially up-regulated in CVB3 infected female mice or that signaling through this TLR directly causes
myocarditis resistance.* Correspondence: sally.huber@uvm.edu
1Department of Pathology, Center for Immunology and Infectious Disease,
University of Vermont, Burlington, VT, USA
Full list of author information is available at the end of the article
© 2012 Roberts et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Roberts et al. Biology of Sex Differences 2012, 3:25 Page 2 of 13
http://www.bsd-journal.com/content/3/1/25Background
Myocarditis is a form of inflammatory heart disease
which clinically affects men (2:1) over women [1]. In
our model of virus-induced myocarditis, coxsackie-
virus, a small positive sense ssRNA picornavirus causes
an autoimmune reaction in the heart following infec-
tion. Autoimmunity most likely results from antigenic
mimicry between viral and heart antigens [2]. Despite
similar levels of viral replication, male mice develop
myocarditis whereas females do not. Several mechan-
isms have been reported for the sex bias associated
with myocarditis including estrogen, γδ T-cells, CD1d,
Regulatory T-cells and more recently, Toll-Like Recep-
tor (TLR) expression [3-8]. TLRs have been implicated
in several autoimmune disease, including systemic
lupus erythematosus, type 1 diabetes, autoimmune en-
cephalomyelitis, and autoimmune myocarditis [8-14].
TLRs are a family of proteins which play a key role in
innate immune defense. Unlike the adaptive immune
response which is highly specific to a distinct antigen
and takes up to 10 days from microbe exposure to op-
timally develop, signaling through TLRs is immediate.
TLRs recognize common motifs uniquely shared by
classes of different pathogens called pathogen asso-
ciated molecular patterns, or PAMPs. Currently, 11
TLRs have been identified in mammals, each interacting
with a specific PAMP including lipids, proteins and nu-
cleic acids [15]. TLRs can show sex bias in expression;
such bias has been shown for TLR7 and TLR9. TLR7 and
TLR9-mediated functions are promoted on pDCs by sig-
naling through estrogen receptor α [16,17]. In contrast,
estradiol may suppress increased expression of TLR4
after LPS stimulation [18,19]. No information on sex bias
of other TLRs, including TLR2, is available.
The goal of this communication was to evaluate
whether the sex bias in CVB3 induced myocarditis sus-
ceptibility was mediated by differences in TLR expres-
sion between male and female mice. PCR array and
microarray analysis were conducted on CVB3 infected
male and female mice at days 0, 3, and 6 post infection.
Female mice were found to have higher levels of car-
diac TLR2 mRNA at 3 days post infection (p.i.) com-
pared to males. Male mice have increased levels of
TLR4 protein on splenic lymphocyte populations com-
pared to females. Treatment of male mice with
PAM3CSK4, synthetic triacylated, lipopeptide (a TLR2-
specific ligand), at the time of infection abrogates the
mortality normally associated with coxsackievirus infec-
tion, whereas female mice treated with ultrapure LPS,
a TLR4 specific ligand, at day 3 post infection resulted
in much greater mortality than observed in female
mice treated with virus and PBS alone. These results
indicate that TLR2, expressed in female mice during




Male and female C57Bl/6 mice were purchased from the
Jackson Laboratories, Bar Harbor Maine. Mice were
housed at the University of Vermont in sterile ventilator
cages. Adult mice ages 6-8 weeks were used in all
experiments. Experiments consisted of groups starting
with a minimum of 5 mice and were repeated at least
two times. Differences in final mouse numbers between
sexes and treatments were due to mortality. All experi-
ments were reviewed and approved by the University of
Vermont Institutional Animal Care and Use Committee.
Virus
The H3 variant of CVB3 was derived from an infectious
cDNA clone which has been described previously [20].
Mice were infected by intra-peritoneal (i.p.) injection of
0.5ml of phosphate-buffered saline (PBS) containing 102
plaque forming units (PFU) of the virus.
Organ viral titers
Hearts were aseptically removed, perfused with PBS, and
weighed before being homogenized in RPMI-1640 media
(Mediatech, Manassas, VA) containing 2% fetal bovine
serum, antibiotic/mycotic, penicillin and streptomycin.
Cellular debris was removed by centrifugation at 300xg
for 10 minutes and the supernatants were subjected to a
series of 10-fold serial dilutions in RPMI-1640-2%FBS
and titers were determined by plaque-forming assay on
HeLa cell monolayers as described previously [20].
Toll-Like receptor agonists
Both the TLR2 ligand Pam3CSK4, a synthetic triacylated,
lipopeptide and the TLR4 ligand Ultrapure LPS isolated
from E.coli 0111.B4 were purchased from Invivogen
San Diego, CA. Both ligands were resuspended in endo-
toxin free water and diluted in PBS for i.p. injection.
PAM3CSK4 was injected at a concentration of 50 ug/mouse
[21,22], and UP-LPS was injected at a concentration of
20mg/kg [23,24].
Lymphocyte preparation
Spleen were aseptically removed and processed through
a fine-mesh screen to produce single-cell suspensions.
Lymphocyte suspensions were centrifuged over Histopa-
que (Sigma Chemical Co., St. Louis, MO).
Mouse TLR pathway PCR array
Male and female C57Bl/6 mice were infected and har-
vested on day 0 (uninfected), 3, or 6 post infection.
Hearts were perfused with 2 ul/ml ribolock RNase
Roberts et al. Biology of Sex Differences 2012, 3:25 Page 3 of 13
http://www.bsd-journal.com/content/3/1/25inhibitor (Fermentas, Maryland, USA) and incubated 2-
4 days in RNAlater (Qiagen, California, USA) according
to manufacturer’s directions. Following perfusion with
ribolock, 1/3 of the heart was removed and prepared for
histology as described. The remaining heart tissue was
cut to 10 mg and homogenized in trizol (Sigma-Aldrich,
Missouri, USA) with a biospec mini- bead beater (Cole-
Parmer, Illinois, USA). RNA was extracted with chloro-
form using the Qiagen RNeasy Mini RNA isolation Kit
(Qiagen, California, USA.) Prepared RNA samples were
evaluated for quality and quantity at the Vermont Can-
cer Center’s Microarray facility. Three representative
hearts from each group were chosen based first on hist-
ology score to ensure infection, then based on RNA
quality and amount of RNA recovered. An aliquot of
each samples were pooled by sex and day and run with
the S.A. Bioscience RT2 Profiler PCR Array Mouse
TLR Pathway PCR Array (PAMM-018) (SA Bioscience,
Qiagen-USA, Valencia CA) at the Vermont Cancer Cen-
ters Microarray Facility at the University of Vermont.Microarray
RNA samples used in the PCR Array were further sub-
jected to microarray analysis. Three representative hearts
from each group were chosen based first on histology
score to ensure infection, then based on RNA quality
and amount of RNA recovered. Samples were indivi-
dually run on the Affymetrix Mouse Gene 1.0st Ar-
ray Chip. Individual results were averaged by group and
submitted to the University of Vermont Bioinformatics
group for analysis.Calculation of probe set statistics and differential
expression
RMA expression statistics from the 12 samples were
modeled in a 2 × 3 block design, sex by day 0, 3, and 6
post infection, with mouse modeled as random effect.
Pairwise linear modeling was conducted using ANOVA
as implemented in PartekW Genomics SuiteTM, version
6.6 (Copyright© 2009, Partek Inc., St. Louis, MO, USA).
ANOVA provided the response (fold change calculated
using the least square mean) and the p-value associated
with each probe set, as well as a step-up, adjusted p-
value for the purpose of controlling the false discovery
rate.
A second ANOVA was performed on the target genes
chosen from the results of the super array, thus improv-
ing the statistical power to detect enrichment in those
probe sets.
Microarray data has been submitted to the Gene
Expression Omnibus, and we are currently awaiting
their reply.RTqPCR
Samples for RTqPCR validation were prepared as
described for the microarray. RNA samples validated
by RTqPCR were independent of those used in the
PCR Array and microarray. Samples were analyzed for
TLR2 expression with the Applied Biosystems TaqManW
Gene Expression Assay for mouse TLR2 (kit#
Mm01213946_m1) (Applied Biosystems, Carlsbad, CA.)
at the Vermont Cancer Center’s DNA facility at the Uni-
versity of Vermont.
Antibodies
FITC conjugated anti-CD3 (clone 17A2), APC-Cy7 or
PerCp-Cy5.5 conjugated anti-CD4 (clone RMA-5), APC
conjugated anti-CD11c (clone HL3), APC-Cy7 conju-
gated anti-CD8a (clone 53-6.7), Alexa 647 conjugated
anti-IL4 (clone 11B11), and PE conjugated anti-IFNγ
(clone XMG1.2) were purchased from BD Pharmagin,
San Diego, CA. PerCp-Cy5.5 conjugated anti-F4/80
(clone BM8), Alexa 647 or PE conjugated anti-TLR2
(clone 6C2), and PE conjugated anti-TLR4 (clone UT41)
were purchased from eBioscience, San Diego, CA. Anti-
bodies were diluted 1:100 in PBS containing 1% Bovine
Serum Albumen (BSA). Negative controls were anti-rat
IgG2a conjugated with the same fluorochromes used
with the antigen-specific antibodies. All antibody mix-




1 × 105 isolated lymphocytes were washed in PBS-
containing 1%BSA and resuspended in 0.1ml PBS-1%
BSA containing 1:100 dilution flourochrome conjugated
antibodies and 1:100 dilution of Fc Block (anti-CD16/
CD32). Cells were stained in the dark at 4°C for 15 min-
utes, washed twice with 1XPBS-1%BSA and fixed with
1XPBS containing 2% parafolmaldehyde for flow ana-
lysis. Cells were analyzed using a BD LSR II flow
cytometer using a single excitation wavelength (488 nm)
and band filters for PerCp-Cy5.5 (695/40nm), FITC (525
nm), PE (575 nm) and APC-Cy7 (633 nm). The excita-
tion wavelength for Alexa 647 is 643 nm and a band fil-
ter of 660/20 nm. The cell population was classified for
cell size (forward scatter) and complexity (side scatter).
A minimum of 10,000 cells were evaluated. Positive
staining was determined based on isotype controls.
Intracellular cytokine staining
1 × 105 spleen cells were cultured for 4 hours in RPMI-
1640 medium containing 10% FBS, antibiotics, 10 ug
brefeldin A (BFA: Sigma), 50 ng/ml phorbol 12-myristate
13-acetate PMA: Sigma) and 500 ng/ml ionomycin
(Sigma). The cells were washed in PBS-1% bovine serum
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incubated on ice in PBS-BSA-BFA containing 1:100 dilu-
tion of FC Block, anti-CD4, and anti-CD8a. Cells were
washed with PBS-BSA-BFA, fixed for 10 minutes in 2%
parafolmaldehyde (PFA) and resuspended in PBS-BSA
containing 0.5% saponin containing 1:100 dilutions Fc
Block, Normal Rat Serum, anti-IL4, and anti-IFNγ for 15
minutes on ice. Cells were washed with PBS-BSA-saponin
followed PBS-BSA and resuspended in 2% PFA.
Histology
Hearts were fixed in 10% formalin, sectioned and stained
with hemotoxylin and eosin. Sections were blindly evalu-
ated by an experienced member of the laboratory on a
scale of 0 to 4 where 0 represents no inflammation, 1
represents 1 to 10 lesions per section, 2 represents 11-20
lesions per sections, 3 represents 21 to 40 lesions per
section, and 4 represents greater than 40 lesions per sec-

















Non significant Non significant
Histology Score
Figure 1 Male mice develop more severe myocarditis than female mi
levels of inflammation than female mice at the Day 6 timepoint (p=<0.001
member of the lab. Figure 1C show representative micrographs, note that
cardiac viral titers as log10 PFU/gram. Despite differences in histology score
and female mice at either Day 0, 3 or 6 post infection. Numbers of mice us
D6=14, D3=9).assumed to be uninfected and removed from data
analysis.Statistical analysis
Students T-test was used to determine differences be-
tween individual mice for histology, organ viral titers
and flow cytometry using SPSS PASW Statistics 18. Sta-
tistics for the agonist histology and titer date (Figure 1)
were analyzed by oneway analysis of variance to com-
pare sexes by treatment groups. A priori pairwise con-
trasts comparing each treatment within sex and
comparing similar treatments between sexes were run.
Mortality was measured by the Mantel-Cox Log rank
test using GraphPad Prism 5. Flow cytometry graphs are
presented as mean number of cells positive spleenocytes
for a specific marker or as mean fluorescent intensity
(MFI) of the specified TLR. Error bars are given as the













B Cardiac Viral Titer
ce despite equivalent viral titers. Figure 1A. Male mice have higher
). Histology was scored blindly on a 1-4 scale by an experienced
the black arrows point to areas of inflammation. Figure 1B shows
, no significant difference was observed in viral load between male
































































































Figure 2 Surface marker staining by flow cytometry demonstrates that at the Day 6 timepoint, female mice have greater numbers of
TLR2-expressing T-cells (CD3) (p=0.036), macrophages (F4/80) (p=0.006) and dendritic cells (CD11c) (p=0.019) compared to males.
Numbers of mice used in this experiment were as follows: Male D6=6, D3=3, D0=3; Female D6=5, D3=4, D0=5.
Table 1 A table of expression statistics for the gender by
day-post-infection interactions for the incremental time
points
A.
Interaction between gender and 3-day post-infection,
ie (F*D3 – F*D0) – (M*D3 – M*D0)
Target Gene FDR Fold Change P-Value
TLR2 1.58e-2 1.27 1.58e-2
B.
Interaction between gender and 6-day versus 3-day
post-infection, ie (F*D6 – F*D3) – (M*D6 – M*D3)
Target Gene FDR Fold Change P-Value
TLR2 2.92e-3 −1.37 2.92e-3
These represent the difference of differences for the expression across the two
factors.
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Male C57Bl/6 mice are more susceptible to CVB3
myocarditis than females
Male and female C57Bl/6 mice were infected with 102
PFU CVB3 and evaluated for myocarditis (Figures 1A
and 1B) and cardiac virus titers (Figure 1C) at 3 and
6 days post infection. Control mice were uninfected.
Myocarditic inflammation was not observed in either
male or female mice 3 days post infection, but by day 6,
both male and female mice showed signs of cardiac in-
flammation with male mice having a higher myocarditis
score than female mice (mean cardiac score 0.54±0.11
for females and 1.75±0.11 for males, p<0.001). Despite
increased myocarditis in males, there was no significant
difference in cardiac virus titer at either day 3 or 6 be-
tween the sexes (Figure 1C).
Super and microarray expression
A targeted expression study using the S.A. Bioscience
RT2 Profiler PCR Array Mouse TLR Pathway superarray
was conducted on cardiac RNA isolated from infected
male and female mice harvested on day 0, 3, and 6 post
infection. The results of this assay suggested TLR2 was
differentially expressed in males and females at day 3
post infection, with females having greater expression ofTLR2 compared to males; data not shown. The primary
goal of the microarray assay was to repeat validate the
super array results with a prospective hypothesis of gen-
der specific differential expression during the course of
infection on a genome-wide level and with independent
replicates. With this prospective hypothesis, TLR2 was
found to be significantly differentially expressed in the
interaction between gender and day of infection from
pre-infection to 3-days post, and from 3-days post to 6-
Table 2 The relative fold change for TLR2 based on the three mRNA assays for the interaction between sex and 3-day
post-infection, and gender and 6-day versus 3-day post-infection
Target Gene: TLR2 Fold Change, PCR Array Fold Change, micorarray Fold Change, RTPCR (ave. ΔCT)
Gender by 3-day post infection 9.624 1.27 1.495693
Gender by 6-day vs. 3-day post infection −12.923 −1.37 0.995534
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array and the microarray was further validated by RT-
PCR conducted on infected cardiac samples independent
of those used in the arrays. Table 2 shows the relative
fold change for TLR2 based on the three independent
RNA assays.
Lymphocyte subpopulations show sex-specific differences
in TLR expression
To determine if the observed differences in TLR expres-
sion also occurred in lymphoid cells at the protein level,
spleens of the male and female mice were removed and
processed for analysis by flow cytometry. While micro-
array analysis showed sex differences in TLR2 expression,
a role for TLR4 in CVB3 myocarditis has also been
shown [25-27]. We were curious to see if there was a sex
bias in TLR4 expression on lymphoid cells, and included
analysis of this TLR in these experiments. Analysis of





















































Figure 3 Male mice show an increase in the number TLR4 expressing
timepoint. In contrast, female mice have greater numbers of TLR4 express
respectively), and dendritic cells at Days 3 (p=0.019) and Day 6 (p=<0.001).
D3=3, D0=3; Female D6=5, D3=4, D0=5.individual cell types [CD3+, CD4+, F4/80+ (monocytes)
or CD11c+ (dendritic cells)] is shown for both number of
cells/ spleen (Figures 2 and 3) and the mean fluorescence
intensity (MFI) which describes the relative amount of
TLR expressed per positive cell (Figures 4 and 5). Evalu-
ation of TLR4 expression was more complex (Figure 4).
TLR4+CD4+ cells were increased in all uninfected and
infected female mice compared to equivalent male ani-
mals. Infected female mice had increased numbers of
TLR4+CD11c+ cells compared to male mice, however no
changed was observed in uninfected mice. Male mice
harvested at day 6 have increased numbers of TLR4-
expressing CD3+ (p=0.009) and F480+ cells (p=0.048).
MFI data showed greater expression of TLR2 on female
CD4+ cells at all three timepoints (p=0.001, 0.001, 0.0036
respectively) and on CD3+ cells at day 6 (p=<0.001).
Male mice, on the other hand, had increased expression
of TLR2 on F480+ cells at days 3 and 6 (p=0.006






















































CD3+ cells (p=0.009) and macrophages (p=0.048) at the Day 6
ing CD4+ cells at all three timepoints (p=<0.001, 0.016, and <0.001







































































Figure 4 Mean Fluorescent Intensity (MFI) data shows sex differences in TLR2 protein expression on lymphocyte populations. Female
mice have higher levels of TLR2 expression on CD3+ cells at Day 6 (p=<0.001) compared to male mice. In addition, CD4+ cells isolated from
female mice have higher levels of TLR2 expression at all three timepoints compared to males (p=0.001, 0.001, and 0.006 respectively). In contrast,
male mice have higher levels of TLR2 expression on macrophage populations at Day 3 (p=0.006) and Day 6 (p=<0.001) relative to female mice.
Male mice also show greater expression of TLR2 on dendritic cells at all three timepoints (p=0.002, <<0.001, and 0.006 respectively). Numbers of
mice used in this experiment were as follows: Male D6=6, D3=3, D0=3; Female D6=5, D3=4, D0=5.
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(Figure 4). Expression levels of TLR4 tended to be
increased in infected males compared to female lympho-
cytes at both day 3 and 6 post infection (Figure 5). These
results indicate that there are inherent differences in
TLR expression in both the heart and in lymphoid cells
in mice early after infection (day 3) prior to inflammation
in the heart.
Treatment with TLR 2 and 4 agonists alters sex
differences in disease mortality
Further evidence for the role of TLR2 and TLR4 in
CVB3 myocarditis was obtained by treating male and fe-
male C57Bl/6 mice with either 50μg PAM3CSK4 (PAM;
TLR2 agonist) or 20 mg/kg Ultra-Pure LPS (UP-LPS;
TLR4 agonist). Control mice were infected and treated
with vehicle control (PBS). Infected males treated with
PBS showed 55% mortality by day 7 post infection com-
pared to only 10% mortality in similarly infected females
(Figure 6). Treatment of male mice with PAM along
with infection significantly reduced mortality to 10%compared to control mice (p=0.0261). Treatment of
males with LPS delayed mortality but did not signifi-
cantly reduce total animal deaths by day 7 post infection.
Treating infected females with either PAM or LPS had
minimal effect on mortality compared to infected PBS
treated animals. There was no significant difference in
mortality in female mice treated with PAM or LPS com-
pared to PBS controls. Treating female mice with LPS
on D3 p.i. resulted in 60% mortality compared to 0%
mortality seen with PBS controls (p=0.0046) indicating
that early stimulation of TLR2 confers a protective effect
whereas TLR4 stimulation causes mortality.
Infected female mice treated with PAM show an in-
crease in cardiac viral titer compared to PBS controls
(p=0.001), however no effect was seen in cardiac inflam-
mation (Figure 7). Male mice treated with PAMs showed
no difference in cardiac inflammation or viral titer com-
pared to PBS controls. Treatment of male mice with LPS
resulted in both increased viral titer (p=0.026) and in-
flammation (p=0.005) compared to PBS controls. LPS













































































Figure 5 MFI shows sex differences in TLR4 protein expression on lymphocyte populations. Male mice have greater levels of TLR4
expression on CD3+, F480+ and CD11c+ cells at all three timepoints (p=<0.001 for all values). In addition, male CD4+ cells have higher levels of
TLR4 at both Day 3 (p=0.039) and Day 6 (p=0.011) compared to females. Numbers of mice used in this experiment were as follows: Male D6=6,
D3=3, D0=3; Female D6=5, D3=4, D0=5.
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(p=0.032) compared to those treated with PAM. Similar
to the results seen with PAM treatment, female mice
treated with LPS have increased viral titers (p=0.001)
compared to PBS controls, however there was no
observed difference in myocarditis score.
Discussion
This communication shows that there is a significant dif-
ference in TLR2 and TLR4 expression between CVB3
infected male and female mice at both the mRNA in the
heart and protein level in lymphoid cells. It should be
noted however that while the initial observations of sex
differences in TLR expression were made based on PCR
array and microarray analysis of infected cardiac tissue,
we have also noted the existence of these differences on
splenic lymphoid populations by flow cytometry. Further,
it shows that signaling through TLR2 and TLR4 has ba-
sically different effects on CVB3 pathogenicity with
TLR2 signaling providing partial protection and TLR4
signaling providing increased pathogenicity, at least inmales. The observation of TLR4 aggravation of myocar-
ditis in males is not unexpected as studies by Fair-
weather and colleagues have previously shown that
TLR4 expression is significantly increased in CVB3
infected male BALB/c mice and that blocking TLR4
reduces myocarditis [27]. Other studies have shown that
TLRs-3, -7, -8, or-9 modulate enteroviral myocarditis
[14,28-37]. However, these studies do not concentrate
on potential sex differences in TLR expression or role in
myocarditis susceptibility. Nor has the role of TLR2 in
CVB3 myocarditis been adequately investigated. A re-
cent study has shown that cardiac myosin acts as an en-
dogenous ligand for TLR2 and 8 and stimulates
dendritic cells in vitro to release pro-inflammatory cyto-
kines [38]. Since myocyte lysis is induced by either virus
replication or host immune response to the virus, infec-
tion should release cardiac myosin into the local envir-
onment, causing one to anticipate that TLR2 could have
a major impact on pathogenicity. However, it was sur-
prising that TLR2 signaling actually induced more pro-
tection that aggravated pathogenicity. Based on the
Figure 6 Treatment of infected mice with TLR 2 or 4 agonist effects survival. Treatment of male mice with PAM3CSK4 at the time of
infection results in better survival (p=0.0261) than those given PBS or LPS which have no difference in survival (Figure 6A). Treatment of female
mice with either agonist at the time of infection does not alter survival (Figure 6B). Administration of LPS to female mice on D3 p.i. results in 60%
mortality compared to 0% mortality seen with PBS controls (p=0.0046) (Figure 6C). Male mice treated with LPS at Day 3 had 100% mortality (data
not shown). Numbers of mice used in these experiments were as follows: Male PBS=10, PAM=9, LPS=16; Female PBS=9, PAM=5, LPS=17.
Roberts et al. Biology of Sex Differences 2012, 3:25 Page 9 of 13
http://www.bsd-journal.com/content/3/1/25in vitro evidence of enhanced pro-inflammatory cytokine
response, one would have expected TLR2 signaling to
promote pathogenicity. The reason for the difference be-
tween the in vitro activation of dendritic cells and the
protection observed in whole mice subsequent to CVB3
infection may be reflected in the complex effects of
CVB3 infection on TLR2 and TLR4 up-regulation in dif-
ferent cell populations. The number of TLR2+ cells is
greatest in female mice at day 6 compared to males and
can be seen most prominently on CD3+, F480+ and
CD11c+ cells. Interestingly, the amount of TLR2 expres-
sion on cells isolated from female mice is greatest on
CD3+ and CD4+ cells at days 3 and 6. Male mice, how-
ever, have greater expression of TLR2 on macrophages
and dendritic cells at both days 3 and 6. Imanishi et al
showed that direct TLR2 signaling of T cells stimulates
production of IFNγ [39], a cytokine previously shown
to be essential for autoimmunity in this model of
CVB3 induced myocarditis [40]. If TLR2 expression is
increased on dendritic cells in male mice, in vitro
activation using cardiac myosin might induce pro-
inflammatory cell responses from cells. However if
TLR2 expression on T cells from male mice is sup-
pressed, there may be less direct activation of T cell
populations. This might be important as TLR2signaling in T cells has been shown to promote Tregu-
latory cell responses [41,42]. Thus, increased TLR2 ex-
pression on T cells in females may explain the increased
Tregulatory cell response observed in CVB3 infected fe-
male mice [43,44].
Why sex differences occur in TLR expression is not
completely understood. Certain of the TLR genes, such
as TLR-8 and TLR7 are on the sex chromosomes or
their expression is controlled by the sex chromosomes
[45,46]. While most genes on the X chromosome
undergo x-inactivation in females to prevent dose re-
sponse differences between males and females, some
genes can escape inactivation. Also, TLR7 has been
shown to translocate to the Y chromosome which would
also affect its expression [46]. TLR2 and TLR4 are not
on the sex chromosomes, however but on chromosome
3 and chromosome 4, respectively in the mouse [47].
Cytokines can modulate TLR expression on immune
cells [48], and it is well established that sex hormones
alter cytokine responses with estradiol and testosterone
having distinct effects on pro- and anti-inflammatory
cytokines [49]. Therefore, it is reasonable that the TLR
expression profiles may vary between the sexes.
In contrast to TLR2 enhancement of T-regulatory

























Figure 7 TLR agonist treatment effects viral titer but not histology score. Male and female mice treated with either LPS or PAM show no
difference in mean histology score (Figure 7A). Figure 7B shows that male mice treated with LPS have greater viral replication in the heart
compared to those treated with either PBS (p=0.005) or PAM (p=0.002). Treatment of female mice either PAM (p=0.001) or LPS (p=0.001) results
in greater viral replication compared to those treated with PBS. In addition, female mice treated with PAM have greater levels of viral replication
compared to male mice given the same treatment (p=0.021). Numbers of mice used in these experiments were as follows: Male PBS=10, PAM=9,
LPS=16; Female PBS=9, PAM=5, LPS=17.
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Ig mucin 3 (TIM3) decreases cardiac inflammation
caused by CD11b+ cells while at the same time increas-
ing CD4+/CD25+/FoxP3+ Treg populations [50]. Fur-
ther studies from their laboratory have shown that male
mice have increased levels of TLR4 expression on
macrophages found in the heart following infection. Ex-
pression of TLR4 is thought to increase the production
of IL-18 which increases IFNγ production through the
MyD88 signaling pathway and is likely responsible for Th1
polarization seen in male mice [8,51]. Our data shows that
male mice at all three time points have higher levels of TLR
4 expression on T-cells and macrophages. Since antigen
presenting cells such as DCs and macrophages are respon-
sible for providing the cytokine environment to polarize T-
cells it makes sense that APCs of male mice would have
higher levels of TLR4 expression which in turn would result
in greater levels of IL-18 production leading to the produc-
tion of more IFNg and Th1 cells [52].The finding of increased viral replication in animals
treated with the TLR2 agonist was unexpected. However,
it is known that specific cytokines/chemokines can alter
coxsackievirus replication. Most notable of these are
the type 1 interferons [53] and CXCL10 [54]. These
cytokines/chemokines may either directly affect virus
replication or alter virus load in the target tissue through
their activation of innate effectors such as natural killer
cells. There is an inverse correlation between the ability
of cardiotropic viruses to induce Type 1 interferons and
their ability to cause myocarditis [55]. Since TLR activa-
tion is the classical method for inducing interferon re-
sponse, it is reasonable that these molecules might affect
virus load, and TLR2 activation has been found to be
crucial to control of other viruses [56]. Therefore, the
question remains why TLR2 activation should enhance
virus load in the heart in CVB3 infection when it has
been shown to promote virus clearance in other viral
models. One possibility is the nature of the virus
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two known cellular receptors for coxsackievirus B3 [57].
Microbial infections can up-regulate expression of DAF
[58] which in the case of CVB3 may lead to enhanced
virus replication. This would be especially true if TLR2
engagement simultaneously promoted Tregulatory cell
activation which suppressed anti-viral host responses. A
similar explanation for why signaling through TLR2 and
TLR4 enhances viral load comes from the shared
adaptor protein MyD88. Studes by Fuse et al have shown
that MyD88-/- mice have reduced viral load and develop
less myocarditis by day 7 than intact controls. These
results suggest that MyD88 is important in the develop-
ment of the pathology accociated with infection. In
addition, levels of the coxsackievirus-adenovirus recep-
tor (CAR-one of the two known receptors for CVB3
which crucial for its internalization) are decreased in the
cardiac tissue of MyD88-/- mice compared to control
animals. Finally, their study shows that IRF-3 is
increased in the hearts of MyD88-/- mice. IRF-3 expres-
sion results in increased type I IFN production which is
responsible for antiviral effects. [59]. While it has been
shown that a deficiency in TLR4 resulted in higher viral
titers it is important to note two key differences in
our methods. First, the TLR4-/- mice used were on the
Balb/c backrgound, whereas our mice were C57Bl/6.
Secondly they evaluated cardiac viral titers at days 2 and
12 post infection, whereas our TLR agonist-treated mice
were harvested on day 7 [26]. Of similar interest, female
PBS-treated mice had slightly higher myocarditis when
compared to male mice treated with PBS. While this is
highly unusual given that male mice have been repeat-
edly shown to be more susceptible, there is a possible
explanation for this observation. It has been shown that
low doses of estrogen actually promote a Th1 cytokine
response (IFNγ) whereas high doses of estrogen favor
are Th2 IL-10 response [60,61]. We have previously
shown that susceptibility of female mice changes during
the different phases of the ovarian cycle with mice
infected during the proesterus phase being more suscep-
tible than those infected during the estrus or metestrus
phases. It is therefore likely that these mice could have
had the appropriate hormone environment to allow for
greater susceptibility [62]. We feel, however, that what is
most important to take away from the agonist studies
are the differences that the two agonists have on myo-
carditis within the sexes in terms of their effect on dis-
ease susceptibility.
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